Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
9.62
+0.42 (4.57%)
Nov 6, 2026, 4:00 PM EST - Market closed
Sutro Biopharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $60 | Buy | Maintains | $60 | +523.70% | Oct 22, 2026 |
| Barclays | Barclays | Buy Maintains $56 | Buy | Maintains | $56 | +482.12% | Oct 19, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 | Buy | Reiterates | $50 | +419.75% | Oct 16, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $49 | Buy | Maintains | $49 | +409.36% | Sep 30, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $48 | Buy | Maintains | $48 | +398.96% | Aug 17, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains n/a | Sell | Maintains | n/a | n/a | Aug 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $50 | Buy | Reiterates | $50 | +419.75% | Aug 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.